Ting‐Tsung Chang
- Epidemiology top 0.1%
- Hepatology top 0.05%
- Infectious Diseases top 1%
- Molecular Biology
- Surgery
- Co-authors
- Rong‐Nan ChienChing‐Lung LaiRichard GuanSeng Gee LimNancy W.Y. LeungPatrick MarcellinDar‐In TaiStephanos J. Hadziyannis
- Topics
- Hepatitis B Virus Studies (79 papers)Hepatitis C virus research (76 papers)Liver Disease Diagnosis and Treatment (62 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Ting‐Tsung Chang
112 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Epidemiology 6.9k
- Hepatology 6.8k
- Infectious Diseases 1.3k
- Molecular Biology 281
- Surgery 244
Countries citing papers authored by Ting‐Tsung Chang
This map shows the geographic impact of Ting‐Tsung Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting‐Tsung Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting‐Tsung Chang more than expected).
Fields of papers citing papers by Ting‐Tsung Chang
This network shows the impact of papers produced by Ting‐Tsung Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting‐Tsung Chang. The network helps show where Ting‐Tsung Chang may publish in the future.
Co-authorship network of co-authors of Ting‐Tsung Chang
This figure shows the co-authorship network connecting the top 25 collaborators of Ting‐Tsung Chang. A scholar is included among the top collaborators of Ting‐Tsung Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting‐Tsung Chang. Ting‐Tsung Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 22 | |
| 2 | 22 | |
| 3 | 38 | |
| 4 | 37 | |
| 5 | 111 | |
| 6 | Durability of HBeAg seroconversion following adefovir dipivoxil treatment for chronic hepatitis B | 7 |
| 7 | 48 | |
| 8 | 17 | |
| 9 | 207 | |
| 10 | Sustained viral load and ALT reduction following 48 weeks of entecavir treatment in subjects with chronic hepatitis B who have failed lamivudine. | 21 |
| 11 | 48 weeks of adefovir dipivoxil (ADV) results in improvement in fibrosis and decreased progression of fibrosis in a double-blind, randomized, placebo-controlled study for the treatment of patients with HBeAg plus chronic hepatitis B. | 3 |
| 12 | 17 | |
| 13 | 5 | |
| 14 | 16 | |
| 15 | GS-98-437 a double-blind, randomized, placebo-controlled study of adefovir dipivoxil (ADV) for the treatment of patients with HBeAg+ chronic hepatitis B infection: 48 week results. | 13 |
| 16 | Effects of extended lamivudine therapy in Asian patients with chronic hepatitis Bbreakdown → | 575 |
| 17 | 38 | |
| 18 | 9 | |
| 19 | 6 | |
| 20 | 46 |
About Ting‐Tsung Chang
Ting‐Tsung Chang is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 113 papers that have together received 7.7k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (79 papers), Hepatitis C virus research (76 papers) and Liver Disease Diagnosis and Treatment (62 papers). The work is most often cited by research in Hepatology (6.8k citations), Epidemiology (6.9k citations) and Infectious Diseases (1.3k citations). Ting‐Tsung Chang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Rong‐Nan Chien, Ching‐Lung Lai, Richard Guan, Seng Gee Lim, Nancy W.Y. Leung, Patrick Marcellin, Dar‐In Tai, Stephanos J. Hadziyannis, G. Kitis and Carol Brosgart. Their work appears in journals such as New England Journal of Medicine, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.